Symbols

BBLG

Bone Biologics·NASDAQ

--(--)

7.05 / 10

Outperform

Analyst coverage is absent. Fund‑flow score is 7.05/10, labeled good, yet inflow ratios are modest and trends negative across all size segments, indicating cautious buying pressure.

Fund Flow Rating

What is the analyst consensus for BBLG?

BBLG holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.05/10 (Outperform).